Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-03-08

Clinical Trial Update: Evaluation of the Efficiency of a Cognitive Remedial Program (PROCOG-SEP) Designed for Multiple Sclerosis Patients [NA]

View source ↗

Summary

An update on a clinical trial evaluating the PROCOG-SEP cognitive remediation program for people with multiple sclerosis, with the trial status currently unknow…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Central Hospital, Nancy, France | Conditions: Cognitive Disorders, Multiple Sclerosis | NA | Status: UNKNOWN